Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Tyra Biosciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 62 | 77 | +15 |
| Shares | 35.8M | 46.9M | +11.1M (+31.0%) |
| Value | $495.2M | $768.4M | +$273.2M (+55.2%) |
New holders (22)
Institutions that held Tyra Biosciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OrbiMed Advisors LLC | 768,638 | $12.6M | 0.25% |
| Sio Capital Management, LLC | 535,741 | $8.79M | 3.06% |
| First Turn Management, LLC | 381,210 | $6.25M | 0.94% |
| ExodusPoint Capital Management, LP | 272,150 | $4.46M | 0.06% |
| Nicholas Investment Partners, LP | 152,968 | $2.51M | 0.26% |
| Oppenheimer & Co Inc | 59,576 | $977.0K | 0.02% |
| Renaissance Technologies LLC | 54,400 | $892.0K | 0.00% |
| Two Sigma Investments, LP | 41,742 | $684.6K | 0.00% |
| ADAR1 Capital Management, LLC | 28,300 | $464.1K | 0.13% |
| Legato Capital Management LLC | 20,259 | $332.2K | 0.04% |
| Walleye Capital LLC | 16,887 | $276.9K | 0.00% |
| Citadel Advisors LLC | 16,789 | $275.3K | 0.00% |
| Jump Financial, LLC | 15,159 | $248.6K | 0.01% |
| Fishman Jay A Ltd | 15,000 | $246.0K | 0.03% |
| Goldman Sachs Group Inc | 14,077 | $230.9K | 0.00% |
| Hudson Bay Capital Management LP | 13,317 | $218.4K | 0.00% |
| PDT Partners, LLC | 12,174 | $199.7K | 0.02% |
| EntryPoint Capital, LLC | 1,345 | $22.1K | 0.02% |
| STRS Ohio | 700 | $11.0K | 0.00% |
| Simplex Trading, LLC | 100 | $1.00K | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 2 | $32 | 0.00% |
| CWM, LLC | 1 | $0 | 0.00% |
Sold out (7)
Institutions that held Tyra Biosciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| EcoR1 Capital, LLC | 137,014 | $1.90M |
| Mariner, LLC | 22,164 | $307.0K |
| Sepio Capital, LP | 10,625 | $147.2K |
| LPL Financial LLC | 10,500 | $145.4K |
| Artia Global Partners LP | 10,253 | $142.0K |
| Acuta Capital Partners, LLC | 8,867 | $122.8K |
| AJOVista, LLC | 4,235 | $58.7K |